Data as of Apr 17
 -0.01 / -0.43%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Curis, Inc. is a drug development company, which is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. The company conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Contact Information

Curis, Inc.
4 Maguire Road
Lexington Massachusetts 02421
P:(617) 503-6500
Investor Relations:
(617) 503-6632



Individual stakeholders9.89%
Other institutional28.85%
Mutual fund holders27.34%

Top Executives

Daniel R. PasseriChief Executive Officer & Director
Ali FattaeyPresident & Chief Operating Officer
Michael P. GrayCFO, Secretary, Treasurer & Chief Business Officer
Jaye VinerChief Medical Officer & Executive Vice President
Mark W. NoelVP-Technology Management & Intellectual Property

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.